159 related articles for article (PubMed ID: 15730116)
1. Community pharmacists' actions when patients use complementary and alternative therapies with medications.
Brown CM; Barner JC; Shah S
J Am Pharm Assoc (2003); 2005; 45(1):41-7. PubMed ID: 15730116
[TBL] [Abstract][Full Text] [Related]
2. Pharmacists' actions when patients use complementary and alternative medicine with medications: A look at Texas-Mexico border cities.
Brown CM; Pena A; Resendiz K
J Am Pharm Assoc (2003); 2011; 51(5):619-22. PubMed ID: 21896460
[TBL] [Abstract][Full Text] [Related]
3. Beliefs, practices and knowledge of community pharmacists regarding complementary and alternative medicine: national cross-sectional study in Lebanon.
Hijazi MA; Shatila H; El-Lakany A; Aboul Ela M; Kharroubi S; Alameddine M; Naja F
BMJ Open; 2019 Mar; 9(3):e025074. PubMed ID: 30852542
[TBL] [Abstract][Full Text] [Related]
4. Use of alternative therapies and their impact on compliance: perceptions of community pharmacists in Texas.
Brown CM
J Am Pharm Assoc (Wash); 1998; 38(5):603-8. PubMed ID: 9782694
[TBL] [Abstract][Full Text] [Related]
5. Availability of and attitudes toward resources on alternative medicine products in the community pharmacy setting.
Nathan JP; Cicero LA; Koumis T; Rosenberg JM; Feifer S; Maltz F
J Am Pharm Assoc (2003); 2005; 45(6):734-9. PubMed ID: 16381421
[TBL] [Abstract][Full Text] [Related]
6. Community pharmacists' knowledge, practices and beliefs about complementary and alternative medicine in Palestine: a cross-sectional study.
Shraim NY; Shawahna R; Sorady MA; Aiesh BM; Alashqar GS; Jitan RI; Abu Hanieh WM; Hotari YB; Sweileh WM; Zyoud SH
BMC Complement Altern Med; 2017 Aug; 17(1):429. PubMed ID: 28851351
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
Varisco TJ; Ogunsanya ME; Barner JC; Fleming ML
J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
[TBL] [Abstract][Full Text] [Related]
8. The role of pharmacists in complementary and alternative medicine in Lebanon: users' perspectives.
Hijazi MA; Shatila H; Omeich Z; El-Lakany A; Ela MA; Naja F
BMC Complement Med Ther; 2021 Mar; 21(1):81. PubMed ID: 33691698
[TBL] [Abstract][Full Text] [Related]
9. Understanding pharmacists' experiences with advice-giving in the community pharmacy setting: a focus group study.
Simmons-Yon A; Roth MT; Vu M; Kavalieratos D; Weinberger M; Rao JK
Patient Educ Couns; 2012 Dec; 89(3):476-83. PubMed ID: 22995598
[TBL] [Abstract][Full Text] [Related]
10. Medical pluralism in action? A case study of community pharmacies in Johannesburg, South Africa.
Gilbert L
J Altern Complement Med; 2004 Jun; 10(3):547-55. PubMed ID: 15253861
[TBL] [Abstract][Full Text] [Related]
11. Community pharmacists' attitudes relating to patients' use of health products in Japan.
Asahina Y; Hori S; Sawada Y
Int J Clin Pharm; 2012 Aug; 34(4):529-37. PubMed ID: 22532015
[TBL] [Abstract][Full Text] [Related]
12. How do pharmacists use and recommend vitamins, minerals, herbals and other dietary supplements?
Marupuru S; Axon DR; Slack MK
BMC Complement Altern Med; 2019 Aug; 19(1):229. PubMed ID: 31438941
[TBL] [Abstract][Full Text] [Related]
13. Pharmacists' patterns of use, knowledge, and attitudes toward complementary and alternative medicine.
Koh HL; Teo HH; Ng HL
J Altern Complement Med; 2003 Feb; 9(1):51-63. PubMed ID: 12676035
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
[TBL] [Abstract][Full Text] [Related]
15. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
Thornton JD; Lyvers E; Scott VGG; Dwibedi N
J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027
[TBL] [Abstract][Full Text] [Related]
16. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
Watkins A; McKee J; Hughes C; Pfeiffenberger T
J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
[TBL] [Abstract][Full Text] [Related]
17. Community pharmacists' professional practices for complementary medicines: a qualitative study in New Zealand.
Barnes J; Butler R
Int J Clin Pharm; 2020 Aug; 42(4):1109-1117. PubMed ID: 32686048
[TBL] [Abstract][Full Text] [Related]
18. Student pharmacists' attitudes toward complementary and alternative medicine.
Noureldin M; Murawski MM; Mason HL; Plake KS
J Am Pharm Assoc (2003); 2013; 53(6):618-25. PubMed ID: 24141360
[TBL] [Abstract][Full Text] [Related]
19. Pharmacy placement of nonprescription nicotine replacement therapy products and community pharmacists' counseling for product use.
Kilfoy BA; Prokhorov AV; Hudmon KS
J Am Pharm Assoc (2003); 2006; 46(6):723-8. PubMed ID: 17176688
[TBL] [Abstract][Full Text] [Related]
20. Pharmacists' personal use, professional practice behaviors, and perceptions regarding herbal and other natural products.
Welna EM; Hadsall RS; Schommer JC
J Am Pharm Assoc (2003); 2003; 43(5):602-11. PubMed ID: 14626753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
